Search Results - "Greupink, R"
-
1
Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review
Published in Placenta (Eastbourne) (01-05-2022)“…At least 80% of pregnant woman in Europe use at least one medication during their pregnancy. The majority of these drugs are prescribed off-label. A better…”
Get full text
Journal Article -
2
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments
Published in Clinical pharmacokinetics (01-08-2022)“…Background and Objective Doravirine is currently not recommended for pregnant women living with human immunodeficiency virus because efficacy and safety data…”
Get full text
Journal Article -
3
Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1
Published in Drug metabolism and disposition (01-03-2013)“…Organic anion-transporting polypeptide 1B1 (OATP1B1) is an important hepatic uptake transporter, of which the polymorphic variant OATP1B1*15 (Asn130Asp and…”
Get full text
Journal Article -
4
Transfer of uremic solutes across the human term placenta: An ex vivo study in the dual-side perfused cotyledon
Published in Placenta (Eastbourne) (15-01-2021)“…An increasing number of women becomes pregnant while suffering from chronic kidney disease (CKD). As a result of decreased renal function, uremic solutes…”
Get full text
Journal Article -
5
Placental disposition of the immunosuppressive drug tacrolimus in renal transplant recipients and in ex vivo perfused placental tissue
Published in European journal of pharmaceutical sciences (01-07-2018)“…Currently, tacrolimus is the most potent immunosuppressive agent for renal transplant recipients and is commonly prescribed during pregnancy. As data on…”
Get full text
Journal Article -
6
Experimental study of diclofenac and its biliary metabolites on anastomotic healing
Published in BJS open (01-08-2018)“…Diclofenac increases the risk of anastomotic leakage, but the underlying mechanism is unknown. As diclofenac is excreted largely as biliary metabolites, the…”
Get full text
Journal Article -
7
-
8
-
9
OP08_6. Novel therapeutic strategy in pregnancy: prevention of transplacental passage by lipid nanoparticles
Published in Pregnancy hypertension (01-09-2023)Get full text
Journal Article -
10
Microbial Glucuronidase Inhibition Reduces Severity of Diclofenac-Induced Anastomotic Leak in Rats
Published in Surgical infections (01-05-2018)“…The non-steroidal anti-inflammatory drug diclofenac has been associated with intestinal anastomotic leakage, although the underlying pathophysiology is…”
Get more information
Journal Article -
11
The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo
Published in The Journal of pharmacology and experimental therapeutics (01-05-2006)“…Hepatic stellate cell (HSC) proliferation is a key event in liver fibrosis; therefore, pharmacological intervention with antiproliferative drugs may result in…”
Get more information
Journal Article -
12
Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell
Published in Journal of hepatology (01-11-2005)“…Hepatic stellate cell (HSC) activation and proliferation are key events in the pathology of liver fibrosis. Inhibiting these parameters, therefore, is a…”
Get full text
Journal Article -
13
Potentials and limitations of the low-molecular-weight protein lysozyme as a carrier for renal drug targeting
Published in Renal failure (01-01-2001)“…Selective targeting of drugs to the kidney may enable an increased renal effectiveness combined with a reduction of extrarenal toxicity. Intrarenal delivery to…”
Get more information
Journal Article -
14
354 Hepatic stellate cell specific delivery of mycophenolic acid as a strategy to treat liver fibrosis
Published in Hepatology (Baltimore, Md.) (2003)Get full text
Journal Article